BIOSINO BIO-TEC (08247) affiliated Zhongsheng Jinan independently developed ZS-2000 fully automatic biochemical analyzer has obtained the medical device registration certificate and has been listed on the market.

date
22:36 20/04/2026
avatar
GMT Eight
China Life Sciences North Control Biotechnology (08247) announced that its subsidiary, China Life Medical Device Technology (Jinan) Co., Ltd. (China Life Jinan), has independently developed the ZS-2000 fully automatic biochemical analyzer, which has recently obtained the Chinese medical device registration certificate (registration certificate number: Lu Xie Zhu Jun 20262220227) issued by the Shandong Province Drug Administration. The acquisition of this registration certificate signifies that the product is now eligible for legal sales and use within China.
BIOSINO BIO-TEC (08247) announced that its subsidiary company Zhongsheng Medical Instrument Technology (Jinan) Co., Ltd. has independently developed the ZS-2000 fully automatic biochemical analyzer, which has recently obtained the Chinese Medical Device Registration Certificate (Registration Certificate Number: Lu Xie Zhu Zheng 20262220227) issued by the Shandong Provincial Drug Administration. The acquisition of this registration certificate signifies that the product is qualified for legal sales and use in China. The ZS-2000 fully automatic biochemical analyzer is mainly used for clinical biochemical testing and can be widely applied in hospital laboratories, third-party medical laboratories, and other medical testing institutions. It features high throughput, automation, and intelligence, which helps to improve testing efficiency and reduce operating costs. The acquisition of this registration certificate not only enhances the group's technical strength in the high-end biochemical analyzer field but also indicates the continuous improvement of the group's overall "instrument + reagent" solution, which helps to enhance the market competitiveness and brand influence of the group's products. In addition, the Board of Directors believes that the successful launch of the ZS-2000 fully automatic biochemical analyzer and the cooperation to launch the ZS-8600 biochemical immunoinstrument will help the group further expand the domestic medical testing market, promote the sales of related supporting reagent products, and align with the group's long-term development strategy.